Yourgene Health is an international molecular diagnostics group which develops and commercialises genomic services and technologies. Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and infectious diseases.
Catalogue No.
ONDYDB1
Technology
Fragment Analysis
No. of Reactions
25
Volume
DPYD screen testing for *2A, *13, c.2846A>T, HapB3
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN0XYB2
Technology
Fragment Analysis
No. of Reactions
50
Volume
QST*R-XYv2 comprises a total of 12 markers for boththe X and Y chromosomes. It can be used to detect sexchromosome aneuploidies.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN021BX
Technology
Fragment Analysis
No. of Reactions
10
Volume
QST*R-21 detects additional chromosome 21 specificmarkers to supplement QST*R and QST*Rplusv2 if required.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN018BX
Technology
Fragment Analysis
No. of Reactions
10
Volume
QST*R-18 detects additional chromosome 18 specificmarkers to supplement QST*R and QST*Rplusv2 if required.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN013BX
Technology
Fragment Analysis
No. of Reactions
10
Volume
QST*R-13 detects additional chromosome 13 specificmarkers to supplement QST*R and QST*Rplusv2 if required.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN003B2
Technology
Fragment Analysis
No. of Reactions
50
Volume
QST*R is a highly multiplexed single tube assay comprisinga total of 16 markers for the detection of the 3 most common viable autosomal trisomies (13, 18 and 21).
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN0PLB2
Technology
Fragment Analysis
No. of Reactions
50
Volume
QST*Rplusv2 is a highly multiplexed single tube assay. It comprises a total of 22 markers for chromosomes 13,18, 21, X and Y and will detect the most common viableautosomal trisomies and sex chromosome aneuploidies.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AN6XYB1
Technology
Fragment Analysis
No. of Reactions
25
Volume
Detects trisomies of chromosome 13, 15, 16, 18, 21, 22, X and Y.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AZFPLBX
Technology
Fragment Analysis
No. of Reactions
10
Volume
Extension assay to Male Factor Infertility, providing additional mapping of AZFabc region deletions.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
AZFXYB1
Technology
Fragment Analysis
No. of Reactions
25
Volume
Simultaneous detection of Y chromosome microdeletions (AZFabc regions) and sex chromosome aneuploidies.
Available for general supply in Australia. Included on the Australian register of Therapeutic Goods (ARTG).
Catalogue No.
CF1UKB1
Technology
Fragment Analysis
No. of Reactions
25
Volume
Bolt on to CFEU2v1 to increase the mutation coverage for the British population.
Not available for general supply in Australia. For Performance Evaluation Use only.
Catalogue No.
CFIBNB1
Technology
Fragment Analysis
No. of Reactions
25
Volume
Bolt on to CFEU2v1 to increase the mutation coverage for the Iberian population.
Not available for general supply in Australia. For Performance Evaluation Use only.